New Strong Sell Stocks for September 23rd
Source: zacks.com

Zacks added Bain Capital Specialty Finance (BCSF), Build-A-Bear Workshop (BBW), and FS Bancorp (FSBW) to its Rank #5 Strong Sell list after downward revisions to current-year consensus earnings estimates. Estimates fell 1.8% for BCSF, 11.6% for BBW, and 4.4% for FSBW over the past 60 days, with BBW facing the largest negative revision. The updates are likely to weigh on sentiment for the three individual stocks but have limited broader market significance.
Analysis
The estimate-revision signal is most investable in BBW, where a double-digit cut implies either traffic, conversion, or promotional assumptions are resetting faster than consensus had modeled. Small specialty retailers typically suffer a nonlinear multiple de-rating when earnings revisions coincide with inventory build or gross-margin pressure; the relevant read-through is not broad discretionary retail but mall- and gifting-exposed peers such as PLCE, GCO and JILL. The next 1-3 month catalyst is management commentary on holiday ordering, markdowns and inventory turns; a reaffirmed margin outlook or evidence that the cut is already reflected in guidance would invalidate a fresh short.
BCSF's revision is less meaningful absent evidence of portfolio deterioration, because BDC earnings are driven primarily by base rates, non-accruals, leverage and realized credit losses rather than a modest consensus change. The more important second-order risk is that lower short rates reduce asset yields before funding costs fully reset, while middle-market stress can force NAV marks and widen the discount to NAV. Treat BCSF as a credit-spread watch: rising non-accruals, a dividend coverage shortfall, or NAV declining by more than 2% sequentially would make the bearish case actionable; absent those datapoints, the signal alone is insufficient.
FSBW is a thinly traded community-bank exposure where earnings revisions may reflect deposit beta, commercial-real-estate provisioning, or mortgage-banking weakness, but liquidity limits tradeability and makes a directional short unattractive. The contrarian point across all three names is that a rank-based downgrade is often backward-looking: BBW and FSBW can gap sharply on a single earnings update, while BCSF's discount to NAV may already price modest deterioration. No inference should be drawn from QBTS appearing in the dataset; it is not supported by a company-specific fundamental development here.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately negative
Sentiment Score
-0.48
Ticker Sentiment
Key Decisions for Investors
- Watch BBW for a short entry only after the next earnings release or pre-holiday update confirms negative comparable-sales or gross-margin guidance; target a 15-20% downside over 1-3 months, with a stop on guidance reaffirmation plus clean inventory-turn improvement. Avoid initiating solely on the estimate revision after a large same-day decline.
- Use a relative-value expression rather than outright retail beta: short BBW versus long a higher-quality discretionary basket or XRT only if BBW's forward EPS revisions remain negative while peer revisions stabilize. Reassess if the relative spread widens 10% without new fundamental deterioration.
- Keep BCSF on a credit-monitor list rather than shorting. Escalate to short BCSF or long protection via a BDC-pair underweight if quarterly non-accruals rise, NAV falls more than 2% sequentially, or dividend coverage drops below 1.0x; those conditions can drive a further 5-10 percentage-point discount-to-NAV widening over 6-12 months.
- Avoid directional FSBW exposure until deposit-cost trends, CRE concentration, and allowance coverage are available. If upcoming results show accelerating deposit beta or incremental CRE provisioning, express regional-bank risk through more liquid KRE exposure rather than a single-name short.
More News
- Is Sterling's $130M-$140M CapEx Plan Fuel for Its Next Growth Leg?
- D-Wave Quantum stock rises on CGI partnership deal
- Burlington's Beauty & Accessories Categories Lead Sales Trends
- Will OPRX's OpenPath Deal Help TTD Capture More Healthcare Ad Dollars?
- Michael Burry adds to shorts as Nasdaq-100 hits all time high. Why he's betting against chips
- Nasdaq Index and S&P500: US Stocks Retreat From Record Highs as Oil and Yields Rise
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Weekly Update: Adding Live MBO Level 3 Data - Liquidity Heatmap, OFI Charts, and More
- Alternative Data Due Diligence for Institutional Investors